Poseida Therapeutics Stock Price

0.11 (2.45%)
Upgrade to Real-Time
Regular Market
Volume 56,002
Bid Price 4.55
Ask Price 4.58
News -
Day High 4.63


52 Week Range


Day Low 4.40
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Poseida Therapeutics Inc PSTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.11 2.45% 4.60 13:27:44
Open Price Low Price High Price Close Price Prev Close
4.51 4.40 4.63 4.49
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
566 56,002 $ 4.49 $ 251,562 - 4.40 - 13.64
Last Trade Time Type Quantity Stock Price Currency
13:28:37 5 $ 4.55 USD


Draw Mode:

Poseida Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 287.53M 62.51M 26.47M $ - $ - -1.83 -2.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 525.60k 1.30%

more financials information »

Poseida Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PSTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.755.054.404.68143,110-0.15-3.16%
1 Month7.027.204.405.56173,583-2.42-34.47%
3 Months6.477.844.406.50169,025-1.87-28.9%
6 Months8.3211.104.407.23183,709-3.72-44.71%
1 Year8.6513.644.408.74234,730-4.05-46.82%
3 Years17.0017.624.409.96273,258-12.40-72.94%
5 Years17.0017.624.409.96273,258-12.40-72.94%

Poseida Therapeutics Description

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Your Recent History
Poseida Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.